Bacterial cell wall and metabolism

The term refers to the coordinated processes by which bacteria synthesize, remodel, and adapt their cell wall — primarily peptidoglycan — in response to environmental changes and stressors, including antibiotic exposure. The bacterial cell wall is a common and highly effective therapeutic target; antibiotics like beta-lactams inhibit specific biosynthetic enzymes involved in peptidoglycan cross-linking, leading to cell lysis and death, especially in actively growing bacteria[1][2][3][5][6]. Bacterial metabolism, which governs energy status, precursor supply, and regulatory responses such as the stringent response, strongly influences susceptibility to cell wall-targeting antibiotics and plays a pivotal role in resistance, persistence, and adaptation[1][4][5]. Modern antibacterial strategies often target these processes directly or exploit their vulnerabilities for selective therapy, but this conceptual category should be broken down into molecular entities for clinical and drug development applications[3][4][5].

Other names

Bacterial cell wallPeptidoglycan biosynthesisBacterial metabolismCell wall-active targetMetabolic target

Inhibition of cell wall biosynthetic enzymes (e.g., PBPs, MurA) Interference with peptidoglycan cross-linking Sequestration/inhibition of cell wall precursors Disruption of metabolic/reductive pathways Induction of bacterial autolysis Generation of toxic metabolic byproducts (e.g., ROS via disrupted metabolism) Efflux inhibition (for some metabolism targets)